Several longitudinal studies offer mixed insights into adiponectin’s influence on metabolic diseases like hypertension, with some linking high levels to reduced metabolic syndrome risk and others to increased mortality and no protection against hypertension [11, 13, 25–29]. The gene discussed is ADIPOQ; the disease is metabolic disease.